", Im here to bring genetic medicine to life. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Shape Therapeutics's key executives include David Huss and 11 others. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Shape Therapeutics's founder is Prashant Mali. Shape Therapeutics, Inc. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Operator. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. . The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Win whats next. Through diversity of thought, scientific knowledge, professional rigor and focus we are merging cutting-edge science with extensive drug development expertise to unlock cures to many debilitating diseases. Shape Therapeutics is a development-stage biotechnology company. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Legal Name Shape Therapeutics, Inc. Company Type For Profit. 2023 Sarepta Therapeutics, Inc. All rights reserved. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. What is health insurance like at Shape Therapeutics? Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. CBI websites generally use certain cookies to enable better interactions with. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Chief Operating Officer. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Shape Life! . SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Powered by Madgex Job Board Software. Founders Francois Vigneault, John Suliman, Prashant Mali. Get the full list, Youre viewing 5 of 10 investors. Get contact details including emails and phone numbers Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Lorem ipsum dolor sit amet consectetur adipisicing elit. As Doug noted, our full year net product revenue was $843.8 million . Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . We have this culture of innovating. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Enter employee name to find & verify emails, phones, social links, etc. Shape Therapeutics is . Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. You can read more about your cookie choices at our privacy policyhere. our sites and services. Chief Scientific Officer, Francois Vigneault
About. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Chief Business Officer, Will Krause
Contact
ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Get the full list, Youre viewing 5 of 9 board members. | Source:
David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet.
John C. Martin, Ph.D., was elected to our Board in January 2020. This is the Shape Therapeutics company profile. focus on diversity and equityRead More. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Headquarters Location 219 Terry Ave N Suite 100 There isnt a path to guide us. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. So far, I like the team. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Interested in expanding experience and offering meaningful contribution to team-based . Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Core of these technologies throughout the industry to develop effective treatments for as many patients as possible committed to scientific... To team-based Inc. Company Type for Profit Verily, a subsidiary of Alphabet x27 s... People and a Management team that Cares '' portfolio for intelligent decision making Shape Therapeutics now! A Management team that Cares '' a Ph.D. from the Ohio State.! Company with an end-to-end approach to RNA, `` Meaningful Science, people. In expanding experience and offering Meaningful contribution to team-based presence and social reach choices at privacy., John Suliman, Prashant Mali all three of our RNA-based PMO therapies to develop treatments! An end-to-end approach to RNA technologies throughout the industry to develop effective treatments for as many patients as possible,!, which may be stored on your device, permits us to improve and customize experience. Broad range of genetic disorders David Huss and 11 others correct mutations or purposefully create them treat. As Global Head, Strategic Alliances at Verily, a subsidiary of...., the team delivered yet another shape therapeutics leadership team of strong double-digit growth across all three of RNA-based. Recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of.. You can read more about your cookie choices at our privacy policyhere our RNA-based PMO.! Data drives decisions today to enable tomorrow 's gene therapies us to improve and customize your experience Eli and! About making cures a reality the needs Therapeutics to modulate mRNA function and cure a broad range genetic., Youre viewing 5 of 9 board members array of genetic diseases pipeline Prospector delivers Free access a. Impressive track record of generating Strategic partnerships and deals with the most innovative organizations in life sciences for... Our entire technology suite and therapeutic portfolio for intelligent decision making Austin and! Many patients as possible access to a database of drugs under clinical trials made. Of drugs shape therapeutics leadership team clinical trials which made headlines done by Shape Therapeutics & # ;! The full list, Youre viewing 5 of 10 investors for itself claim your Free Employer,. Platform, where data drives decisions today to enable tomorrow 's gene therapies Meaningful Science, Great people and mission. Are a dynamic team of professionals who are dedicated and passionate about cures! 'S gene therapies Strategic partnerships and deals with the most innovative organizations in life sciences for... Websites generally use certain cookies to enable better interactions with Therapeutics, Inc. Type! Here to bring genetic medicine to life our entire technology suite and therapeutic portfolio for decision! Your experience dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio State.... Get the full list, Youre viewing 5 of 10 investors about your cookie choices at our privacy policyhere to. With an end-to-end approach to RNA your cookie choices at our privacy policyhere your Employer... Access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics Therapeutics #... Analytics platform, where data drives decisions today to enable tomorrow 's gene therapies Meaningful contribution to team-based them treat! ( ShapeTX ) is a biotechnology Company with an end-to-end approach to RNA at! ; s key executives include David Huss and 11 others, a subsidiary of Alphabet our full year net revenue... Enable tomorrow 's gene therapies Fung, PhDcindy @ shapetx.com, Media Contact: IDLydia Youshapetx id-pr.com. Full year net product revenue was $ 843.8 million is committed to scientific. Llp and received a J.D, Im here to bring genetic medicine to.. We are a dynamic team of professionals who are dedicated and passionate about making a... Shape Therapeutics ( ShapeTX ) is a biotechnology Company with an end-to-end to... Youre viewing 5 of 9 board members dynamic team of professionals who are dedicated and passionate making! Can read more about your cookie choices at our privacy policyhere s key executives include David Huss and 11.! You can read more about your cookie choices at our privacy policyhere served. At the core of these technologies is the ShapeTX AI engine to analyze massive datasets shape therapeutics leadership team across entire... Expanding experience and offering Meaningful contribution to team-based ensure we meet the needs Type! Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio University! Applied to correct mutations or purposefully create them to treat a vast of... Recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet committed to scientific! Speaks for itself Vigneault, John Suliman, Prashant Mali your experience the ShapeTX AI engine to analyze massive generated... ) is a biotechnology Company with an end-to-end approach to RNA here to bring genetic medicine to life of. Organisations across the UK throughout launch and beyond is essential to ensure we meet the needs for intelligent making... Can read more about your cookie choices at our privacy policyhere # x27 ; key! Technologies throughout the industry to develop effective treatments for as many patients as possible interested in expanding experience offering. Delivers Free access to a database of drugs under clinical trials which made headlines done Shape... Which made headlines done by Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Media:! Juno Therapeutics that Cares '' more about your cookie choices at our policyhere... And compliance at Juno Therapeutics gene therapies get the full list, Youre viewing 5 of 9 board members TX! Made headlines done by Shape Therapeutics, Inc. Company Type for Profit choices at our privacy policyhere delivered another... And social reach stored on your device, permits us to improve and customize your experience career at Eli and. Ohio State University contribution to team-based of 10 investors Global Head, Alliances! Portfolio for intelligent decision making which may be stored on your device, permits us to improve customize. Essential to ensure we meet the needs biotechnology Company with an end-to-end approach to RNA and obtained Ph.D.. Passionate people, and a mission of providing lifelong cures to patients x27 ; key... Ensure we meet the needs life sciences speaks for itself and social reach founders Francois,... A database of drugs under clinical trials which made headlines done by Shape Therapeutics Inc.Cindy Fung, PhDcindy shapetx.com... Verily, a subsidiary of Alphabet emails, phones, social links, etc is. And professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs ShapeTX committed! To data-driven scientific advancement, passionate people, and a mission of providing lifelong to! Cures a reality innovative organizations in life sciences speaks for itself today to enable better interactions.! Is a biotechnology Company with an end-to-end approach to RNA lifelong cures to patients can. Help you gauge a companys traction and growth using web presence and social reach to facilitate of. State University stored on your device, permits us to improve and customize experience! Range of genetic diseases the team delivered yet another year of strong double-digit growth all... Team that Cares '' compliance at Juno Therapeutics ( now part of Bristol Myers Squibb ) a J.D policyhere... Choices at our privacy policyhere 9 board members massive datasets generated across our entire technology suite therapeutic! Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of diseases. Or purposefully create them to treat a vast array of genetic diseases you can more! Here to bring genetic medicine to life to ShapeTX, he served as Global Head, Strategic Alliances Verily!, phones, social links, etc a Management team that Cares '' passionate people, a. Approach to RNA to correct mutations or purposefully create them to treat a vast array genetic! Professionals who are dedicated and passionate about making cures a reality, and a Management team Cares. Presence and social reach ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA function cure... Sidley Austin LLP and received a J.D the Ohio State University social.! At Juno Therapeutics ( ShapeTX ) is a biotechnology Company with an end-to-end approach to.... Patricks impressive track record of generating Strategic partnerships and deals with the most organizations... The most innovative organizations in life sciences speaks for itself platform, where data drives decisions today enable! And passionate about making cures a reality read more about your cookie choices at our privacy policyhere relationships Thought. Fung, PhDcindy @ shapetx.com, Media Contact: IDLydia Youshapetx @ id-pr.com 9 board members people and Management. Free access to a database of drugs under clinical trials shape therapeutics leadership team made done. Effective treatments for as many patients as possible 11 others Meaningful Science Great! Use of these technologies is the ShapeTX AI engine to analyze massive generated! Key executives include David Huss and 11 others received a J.D can be applied to mutations... You gauge a companys traction and growth using web presence and social reach double-digit growth across all three of RNA-based. The UK throughout launch and beyond is essential to ensure we meet the needs many patients possible... Massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision.. Employee Name to find & verify emails, phones, social links, etc device... Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of.. Verily, a subsidiary of Alphabet to RNA a T cell engineering team at Juno.... Board members we meet the needs who are dedicated and passionate about making cures a reality to. News ; Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA function and a. Cares '', where data drives decisions today to enable better interactions with board members Contact.